<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=384506&amp;fmt=gif">
Skip to content
    December 20, 2018

    Recorded Webinar: New Strategies in Antibiotic Drug Development

    CDD Webinar Recorded Live Logo

    Webinar discussing Antibiotic Drug Development

    Recorded December 13, 2018

    The discussion was highly informed, with a focus on how we can move the needle in the challenging antibacterial drug discovery arena.

    • Further our understanding of the compound types that penetrate the various compartments of Gram-Negative Bacteria via various mechanisms and equilibrium processes.
    • Explore the broader business and scientific considerations that influence successfully navigating novel antibiotics development.



    Webinar Summary

    This talk was hosted by CDD, in conjunction with Pew Trusts and moderated by Keystone Symposia CSO, Dr. Thale Jarvis, with an introduction from Dr. Wes Kim, Senior Officer of Pew Trust's Antibiotic Resistance Project.

    If you enjoyed this webinar, you will also like others in our series available here.

    You'll also find short bios with links to learn more about this webinar's speakers and moderators below.

    Featuring These Leading Scientists...

    Dr AJ Campbell, CDD Q4 2018 Webinar Speaker. Collaborative Drug Discovery

    AJ Campbell


    AJ Campbell is a computational chemist in the Medicinal Chemistry Group of the Stanley Center for Psychiatric Research at the Broad Institute of the Massachusetts Institute of Technology and Harvard University.

    Dr. Campbell is also skilled in drug design and discovery, molecular dynamics, medicinal chemistry, and structural biology.

    Dr Cheryl Quinn, CDD Q4 2018 Webinar Speaker. Collaborative Drug Discovery

    Cheryl Quinn


    Cheryl Quinn was Director of Antibacterial Biology at Pfizer and a senior executive at several biotechnology companies focusing on novel antibacterials and antifungals discovery.

    An active reviewer for NIH study sections for over 10 years, Dr. Quinn has also led business efforts, culminating in her tenure as CEO of ImmuVen Inc., a T-cell receptor-based technology company. She is an inventor on 42 issued patents.

    Thale Jarvis, CDD Q4 2018 Webinar Moderator. Collaborative Drug Discovery

    Thale Jarvis


    Thale Jarvis is a member CDD's Customer Advisory Board and is currently CSO at Keystone Symposia. Dr. Jarvis is also Co-Founder, Science Advisor and Vice President of R&D at Crestone, working on C. difficile drug discovery.

    Dr. Jarvis is a co-author of 40 publications and a co-inventor of over a dozen issued patents.

    Wes Kim, CDD Q4 2018 Webinar Facilitator. Collaborative Drug Discovery

    Wes Kim


    Wes Kim is Senior Officer, Innovation for the  Antibiotic Resistance Project at the Pew Charitable Trusts where he leads efforts to spur the innovation of new antibiotics for Pew's antibiotic resistance project.

    Dr. Kim's work focuses on research and policies that will help to advance antibiotic discovery and development.


    Tag(s): CDD Blog , Webinars

    Other posts you might be interested in

    View All Posts
    CDD Blog
    9 min   April 19, 2024
    Drug Discovery Industry Roundup with Barry Bunin — April 19, 2024
    Read More
    CDD Blog
    2 min   April 19, 2024
    CDD Appoints Yasushi Hamagashira as Head of Sales and Marketing for Japan
    Read More
    24 min   April 19, 2024
    Recap of CDD 20th Anniversary UGM – South San Francisco 2024
    Read More